BOLNO PAUL — SEC Form 4 filings
SEC reporting owner CIK 1657710. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-07 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 636,930 shares, $7,073,672 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 217,351 shares @ $10.10 ($2,194,810) in Wave Life Sciences Ltd., filed 2025-08-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Wave Life Sciences Ltd. (WVE) | President and CEO, Director | 9 | — | 7 legs · 636,930 sh · $7,073,672 | 10 |
| Invivyd, Inc. (IVVD) | Director | 2 | — | — | 2 |
Form 4 filings — BOLNO PAUL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4 | Invivyd, Inc. (IVVD) | Grant/award (A): 32,876 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 165,000 @ $0 · Sale (S): 10,480 @ $13.45 · Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2025-09-24 | 4 | Invivyd, Inc. (IVVD) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-08-26 | 4 | Wave Life Sciences Ltd. (WVE) | Sale (S): 217,351 @ $10.10 | EDGAR |
| 2025-03-07 | 4 | Wave Life Sciences Ltd. (WVE) | Option exercise (M): 169,025 @ $2.48 · Sale (S): 169,025 @ $9.57 · Option exercise (M): 120,966 (derivative) @ $0 · Option exercise (M): 48,059 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 121,000 @ $0 · Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Wave Life Sciences Ltd. (WVE) | Option exercise (M): 50,000 @ $2.48 · Sale (S): 50,000 @ $15 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-11-15 | 4 | Wave Life Sciences Ltd. (WVE) | Sale (S): 51,234 @ $14.32 | EDGAR |
| 2024-10-18 | 4 | Wave Life Sciences Ltd. (WVE) | Sale (S): 90,474 @ $15 | EDGAR |
| 2024-08-23 | 4 | Wave Life Sciences Ltd. (WVE) | Sale (S): 48,366 @ $5.78 | EDGAR |
| 2024-02-07 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 1,008,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1657710 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →